Home/Filings/4/0001562180-16-001732
4//SEC Filing

Sagent Pharmaceuticals, Inc. 4

Accession 0001562180-16-001732

CIK 0001369786operating

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 12:41 PM ET

Size

4.8 KB

Accession

0001562180-16-001732

Insider Transaction Report

Form 4
Period: 2016-02-18
Drake Lorin
VP, Sales and Marketing
Transactions
  • Tax Payment

    Common Stock

    2016-02-18$15.16/sh452$6,85232,077 total

Issuer

Sagent Pharmaceuticals, Inc.

CIK 0001369786

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001369786

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 12:41 PM ET
Size
4.8 KB